Family-Driven Goals to Improve Care for Children With Autism Spectrum Disorder

Katherine R Bellesheim1,2, Lynn Cole3, Daniel L Coury4

  • 1Thompson Center for Autism and Neurodevelopmental Disorders, and.

Pediatrics
|August 16, 2018
PubMed

Insights

Standardized care pathways for constipation and insomnia in children with autism spectrum disorder (ASD) were implemented. A family-centered approach improved goal attainment for 75% of families, enhancing management of these common conditions.

Area of Science:

  • Pediatric Gastroenterology
  • Pediatric Neurology
  • Developmental Pediatrics

Background:

  • Constipation and insomnia are prevalent in children with autism spectrum disorder (ASD), often undertreated.
  • Standardized care pathways are needed to address these co-occurring conditions in ASD populations.

Purpose of the Study:

  • To implement and refine constipation and insomnia practice pathways for children with ASD.
  • To improve the standardization of care for these common conditions in clinical settings.

Main Methods:

  • Eleven Autism Treatment Network sites implemented constipation or insomnia practice pathways within a Learning Collaborative.
  • A multidisciplinary quality improvement team approach was used, with gradual patient increases and pathway refinement.
  • Family-driven goal setting was incorporated to tailor interventions.

Main Results:

  • 82 children with ASD and constipation and 101 with ASD and insomnia were managed.
  • Pathway refinements, including family-centered goal setting, improved adherence and communication.
  • 75% of families achieved at least one intervention goal, with a median time to improvement of 6 weeks.

Conclusions:

  • Integrating a family-centered approach into standardized care pathways can enhance engagement and adherence.
  • These refined pathways show promise for improving the management of constipation and insomnia in children with ASD.
  • Standardization of care through practice pathways can lead to better health outcomes for children with autism spectrum disorder.
Abstract

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
1.2K
Protein Families02:47

Protein Families

Protein families are groups of homologous proteins; that is, they have similarities in amino acid sequences and three-dimensional structures. Protein families usually occur because of gene duplication, where an additional copy of a gene is inserted into the genome of an organism.   Mutations that change the amino acids but still allow the protein to be properly synthesized, will lead to new protein family members.   If these new proteins contain similar amino acids in key...
17.0K
Protein Families02:47

Protein Families

4.5K
Gene Families01:57

Gene Families

Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
10.0K
Gene Families01:57

Gene Families

3.8K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
542